Long non-coding RNA TCONS_00000200 as a non-invasive biomarker in patients with intracranial aneurysm. Issue 11 (22nd November 2019)

• Record Type: Journal Article
• Authors: Wu, Chenghan; Song, Hailong; Wang, Yinzhou; Gao, Lili; Cai, Yali; Cheng, Qiong; Chen, Yanru; Zheng, Zheng; Liao, Yuansheng; Lin, Jushan; Xie, Buni; Cai, Weiwu; Li, Shiju; Liao, Lianming; Yan, Xiaohua
• Is Part Of: Bioscience reports. Volume 39:Issue 11(2019)
• Publication Date: 2019-11-22
• Subjects: biomarker -- intracranial aneurysm -- lncRNA -- microarray -- mRNA; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20182224
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract: We performed long non-coding RNA (lncRNA) microarray assay to identify lncRNAs with differential expression between patients with intracranial aneurysm (IA) and healthy control individuals to evaluate their potential use as biomarkers of IA. Arraystar Human lncRNA Microarray v3.0 was performed to identify differentially expressed lncRNAs and mRNAs in plasma samples (4 ml). lncRNAs with the most pronounced differential expression were used to select gene markers, and results were validated by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Plasma levels of TCONS_00000200 (fold change: 2.28) and ENST00000511927 (fold change: 2.50) were significantly higher in IA patients than in healthy individuals ( P <0.001), and plasma levels of ENST00000421997 (fold change: 0.45) and ENST00000538202 (fold change: 0.43) were significantly lower in IA patients than in healthy individuals ( P <0.001). qRT-PCR confirmed the same trends of up- and down-regulation of these four lncRNAs. A receiver operating characteristic (ROC) curve for TCONS_00000200 showed that the area under the curve (AUC) was 0.963 (95% confidence interval, 0.919–1.000), optimal cut-off point was 0.0081, sensitivity was 90.0%, and specificity was 96.7%. These results indicate that the lncRNA TCONS_00000200 is differentially expressed in the plasma of IA patients and could serve as a biomarker of IA.